Bio Active Stent TITAN2

Centre hospitalier, Compiègne, S.Sayah (French document)
Interview of Dr Sayah interventional cardiologist in Compiègne Hospital, France, about his usage of TITAN2 BAS. Dr Sayah presents a clinical case performed with the TITAN2 BAS.
View document (pdf file, 526Kb)

Very late stent thrombosis of a paclitaxel-eluting stent after left main coronary artery stenting

Bern Hospital, Stéphane Cook, Peter Wenaweser, Christian Seiler
We report the case of a 60-year-old male who was treated by implantation of one drug eluting stent in the distal left main coronary artery and the ostial left anterior descending artery for an acute anterior ST-elevation myocardial infarction and who developed stent thrombosis and cardiogenic shock seven-hundred thirty days after stent implantation by complete occlusion of the distal left main coronary stem. This case report highlights that very late stent thrombosis (>1 year) may occur with drug eluting stents, which requires careful clinical follow-up and particularly so with stents implanted into the left main coronary artery.
View document (pdf file, 255Kb)

Bioactive coronary stenting in a complex population. BIOSTEP: A single centre register on No-Eluting stenting

Department of Interventional Cardiology.
IsMeTT - University of Pittsburgh Medical Centre, European Section, Palermo, Italy, R.Baglini, MD, PhD
TITAN 2 NO covered stent shows high performance in complex coronary patients.
View document (pdf file, 1878Kb)